127 related articles for article (PubMed ID: 35403812)
1. Outcome of retinoblastoma treatment protocol in Cameroon as per SIOP-PODC recommendation for a low-income setting.
Kruger M; van Elsland SL; Afungchwi GM; Bardin R; Njodzeka B; Kouya F; Nfor P; Nana P; Wharin P; Hesseling PB
Pediatr Blood Cancer; 2022 Aug; 69(8):e29642. PubMed ID: 35403812
[TBL] [Abstract][Full Text] [Related]
2. SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries.
Chantada G; Luna-Fineman S; Sitorus RS; Kruger M; Israels T; Leal-Leal C; Bakhshi S; Qaddoumi I; Abramson DH; Doz F;
Pediatr Blood Cancer; 2013 May; 60(5):719-27. PubMed ID: 23335388
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
Pérez V; Sampor C; Rey G; Parareda-Salles A; Kopp K; Dabezies AP; Dufort G; Zelter M; López JP; Urbieta M; Alcalde-Ruiz E; Catala-Mora J; Suñol M; Ossandon D; Fandiño AC; Croxatto JO; de Dávila MTG; Reaman G; Ravindranath Y; Chantada GL
JAMA Ophthalmol; 2018 Jul; 136(7):747-752. PubMed ID: 29799944
[TBL] [Abstract][Full Text] [Related]
4. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R
Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
[TBL] [Abstract][Full Text] [Related]
5. Improving Care for Children With Cancer in Low- and Middle-Income Countries--a SIOP PODC Initiative.
Arora RS; Challinor JM; Howard SC; Israels T
Pediatr Blood Cancer; 2016 Mar; 63(3):387-91. PubMed ID: 26797891
[TBL] [Abstract][Full Text] [Related]
6. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.
Radhakrishnan V; Kashyap S; Pushker N; Sharma S; Pathy S; Mohanti BK; Vishnubhatla S; Ghose S; Bakhshi S
Ophthalmology; 2012 Jul; 119(7):1470-7. PubMed ID: 22463820
[TBL] [Abstract][Full Text] [Related]
7. The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide.
Varan A; Kiratli H; Aydın B; Tarlan B; Poyraz CB; Akyüz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2012 Sep; 29(6):529-37. PubMed ID: 22759219
[TBL] [Abstract][Full Text] [Related]
8. Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation.
Sullivan EM; Wilson MW; Billups CA; Wu J; Merchant TE; Brennan RC; Haik BG; Shulkin B; Free TM; Given V; Rodriguez-Galindo C; Qaddoumi I
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e335-40. PubMed ID: 24577551
[TBL] [Abstract][Full Text] [Related]
9. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
10. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
[TBL] [Abstract][Full Text] [Related]
11. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.
Mustafa MM; Jamshed A; Khafaga Y; Mourad WA; Al-Mesfer S; Kofide A; El-Husseiny G; Gray A
J Pediatr Hematol Oncol; 1999; 21(5):364-9. PubMed ID: 10524448
[TBL] [Abstract][Full Text] [Related]
13. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
14. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
[TBL] [Abstract][Full Text] [Related]
15. Role of PET/CT in staging and evaluation of treatment response after 3 cycles of chemotherapy in locally advanced retinoblastoma: a prospective study.
Radhakrishnan V; Kumar R; Malhotra A; Bakhshi S
J Nucl Med; 2012 Feb; 53(2):191-8. PubMed ID: 22251556
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA).
Luna-Fineman S; Barnoya M; Bonilla M; Fu L; Baez F; Rodríguez-Galindo C
Pediatr Blood Cancer; 2012 Apr; 58(4):545-50. PubMed ID: 21910211
[TBL] [Abstract][Full Text] [Related]
17. The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global.
Sullivan M; Bouffet E; Rodriguez-Galindo C; Luna-Fineman S; Khan MS; Kearns P; Hawkins DS; Challinor J; Morrissey L; Fuchs J; Marcus K; Balduzzi A; Basset-Salom L; Caniza M; Baker JN; Kebudi R; Hessissen L; Sullivan R; Pritchard-Jones K;
Pediatr Blood Cancer; 2020 Jul; 67(7):e28409. PubMed ID: 32400924
[TBL] [Abstract][Full Text] [Related]
18. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O
Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
20. SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings.
Parikh NS; Howard SC; Chantada G; Israels T; Khattab M; Alcasabas P; Lam CG; Faulkner L; Park JR; London WB; Matthay KK;
Pediatr Blood Cancer; 2015 Aug; 62(8):1305-16. PubMed ID: 25810263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
